@article{97b3c7beb89f4729b8f8390c8aeaf58f,
title = "Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study",
keywords = "meta-analysis, uveal melanoma, trial design, survival benchmarks, STAGE-IV MELANOMA, PHASE-II TRIAL, GEMCITABINE PLUS TREOSULFAN, LIVER METASTASES, CHEMOEMBOLIZATION TACE, CHOROIDAL MELANOMA, 1ST-LINE TREATMENT, INTRAARTERIAL, TEMOZOLOMIDE, COMBINATION",
author = "L. Khoja and Atenafu, {E. G.} and S. Suciu and S. Leyvraz and T. Sato and E. Marshall and U. Keilholz and L. Zimmer and Patel, {S. P.} and S. Piperno-Neumann and J. Piulats and Kivela, {T. T.} and C. Pfoehler and S. Bhatia and P. Huppert and {Van Iersel}, {L. B. J.} and {De Vries}, {I. J. M.} and N. Penel and T. Vogl and T. Cheng and G. Fiorentini and F. Mouriaux and A. Tarhini and Patel, {P. M.} and R. Carvajal and Joshua, {A. M.}",
year = "2019",
month = aug,
doi = "10.1093/annonc/mdz176",
language = "English",
volume = "30",
pages = "1370--1380",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "8",
}